Harvey J. Mamon

7.8k total citations
154 papers, 4.5k citations indexed

About

Harvey J. Mamon is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Harvey J. Mamon has authored 154 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Oncology, 68 papers in Surgery and 62 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Harvey J. Mamon's work include Pancreatic and Hepatic Oncology Research (33 papers), Gastric Cancer Management and Outcomes (32 papers) and Esophageal Cancer Research and Treatment (26 papers). Harvey J. Mamon is often cited by papers focused on Pancreatic and Hepatic Oncology Research (33 papers), Gastric Cancer Management and Outcomes (32 papers) and Esophageal Cancer Research and Treatment (26 papers). Harvey J. Mamon collaborates with scholars based in United States, Canada and China. Harvey J. Mamon's co-authors include Theodore S. Hong, Thomas M. Roberts, G. Mike Makrigiorgos, Brian M. Wolpin, Jeffrey A. Meyerhardt, Tracy A. Balboni, Matthew H. Kulke, Reuben Gobezie, Robert J. Mayer and Ross Berbeco and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Harvey J. Mamon

145 papers receiving 4.4k citations

Peers

Harvey J. Mamon

ONCOL

PRM

SURGE

Andrew Kramar France

Daniel M. Aebersold Switzerland

Alexander Reinthaller Austria

Jason Chia‐Hsien Cheng Taiwan

Thomas Brunner Germany

Hiroyuki Katoh Japan

Peter Bronsert Germany

Stephan Störkel Germany

Anthony M. Magliocco Canada

Tetsuo Akimoto Japan

Andrew Kramar France

Harvey J. Mamon

1.9k ×1.1

ONCOL

1.1k ×0.8

PRM

1.1k ×0.8

1.1k ×0.9

SURGE

809 ×1.1

Citations per year, relative to Harvey J. Mamon Harvey J. Mamon (= 1×) peers Andrew Kramar

Countries citing papers authored by Harvey J. Mamon

Since Specialization

Citations

This map shows the geographic impact of Harvey J. Mamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey J. Mamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey J. Mamon more than expected).

Fields of papers citing papers by Harvey J. Mamon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey J. Mamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey J. Mamon. The network helps show where Harvey J. Mamon may publish in the future.

Co-authorship network of co-authors of Harvey J. Mamon

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey J. Mamon. A scholar is included among the top collaborators of Harvey J. Mamon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey J. Mamon. Harvey J. Mamon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mamon, Harvey J., Qiuling Shi, K.S. Smith, et al.. (2024). Radiation Quality Control in the PROSPECT Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S117–S117.

Weiser, Martin R., Qian Shi, George J. Chang, et al.. (2023). 597P Surgical quality for patients (pts) treated with neoadjuvant chemotherapy vs chemoradiation for locally advanced rectal cancer (LARC): PROSPECT (NCCTG N1048, alliance). Annals of Oncology. 34. S431–S432. 1 indexed citations

Lee, Shing Fung, et al.. (2022). Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer. Clinical and Translational Radiation Oncology. 36. 83–90. 8 indexed citations

Roberts, H.J., Elizabeth Huynh, Christopher L. Williams, et al.. (2021). Impact of Stereotactic MR-Guided Adaptive Radiation Therapy on Early Clinical and Dosimetric Outcomes in Patients With Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 111(3). e72–e72. 1 indexed citations

Shah, Manish A., Jaafar Bennouna, Toshihiko Doi, et al.. (2021). KEYNOTE-975 Study Design: a Phase III Study of Definitive Chemoradiotherapy Plus Pembrolizumab in Patients with Esophageal Carcinoma. Future Oncology. 17(10). 1143–1153. 78 indexed citations

Konieczkowski, David J., Bhupendra Rawal, Brendan Reardon, et al.. (2019). The Genomic Landscape of Anal Cancer and Its Relationship to Clinical Outcomes: An Exploratory Analysis of NRG Oncology/RTOG 98-11. International Journal of Radiation Oncology*Biology*Physics. 105(1). S104–S105.

Yang, Tingsong, et al.. (2019). The Survival Benefit From the Addition of Radiation to Chemotherapy in Gastric Cancer Patients Following Surgical Resection. Clinical Oncology. 32(2). 110–120. 6 indexed citations

Muralidhar, Vinayak, Ryan David Nipp, Harvey J. Mamon, et al.. (2018). Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer. Annals of Surgical Oncology. 25(13). 4027–4034. 21 indexed citations

Gilbert, Jackie, Brian M. Wolpin, Thomas E. Clancy, et al.. (2017). Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification. Annals of Oncology. 28(9). 2067–2076. 64 indexed citations

10.

Mouw, Kent W., James M. Cleary, Brendan Reardon, et al.. (2016). Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma. Clinical Cancer Research. 23(12). 3214–3222. 36 indexed citations

11.

Wolpin, Brian M., Douglas A. Rubinson, Xiaoxu Wang, et al.. (2014). Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma. The Oncologist. 19(6). 637–638. 289 indexed citations

12.

Russo, Andrea, David P. Ryan, Darrell R. Borger, et al.. (2013). Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer. Journal of Gastrointestinal Cancer. 45(1). 34–39. 34 indexed citations

13.

Wo, Jennifer Y., Sam S. Yoon, Alexander R. Guimarães, et al.. (2012). Gastric lymph node contouring atlas: A tool to aid in clinical target volume definition in 3-dimensional treatment planning for gastric cancer. Practical Radiation Oncology. 3(1). e11–e19. 17 indexed citations

14.

Mamon, Harvey J., Donna Niedzwiecki, Donna Hollis, et al.. (2010). A phase 2 trial of gemcitabine, 5‐fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma. Cancer. 117(12). 2620–2628. 23 indexed citations

15.

Mak, Raymond H., Ellen P. McCarthy, Prajnan Das, et al.. (2010). Adoption of Preoperative Radiation Therapy for Rectal Cancer From 2000 to 2006: A Surveillance, Epidemiology, and End Results Patterns-of-Care Study. International Journal of Radiation Oncology*Biology*Physics. 80(4). 978–984. 16 indexed citations

16.

Hong, Theodore S., Joseph H. Killoran, Marcelo Mamede, & Harvey J. Mamon. (2008). Impact of Manual and Automated Interpretation of Fused PET/CT Data on Esophageal Target Definitions in Radiation Planning. International Journal of Radiation Oncology*Biology*Physics. 72(5). 1612–1618. 25 indexed citations

17.

Balboni, Tracy A., Peter Gaccione, Reuben Gobezie, & Harvey J. Mamon. (2007). Shielding of the Hip Prosthesis During Radiation Therapy for Heterotopic Ossification is Associated with Increased Failure of Prophylaxis. International Journal of Radiation Oncology*Biology*Physics. 67(5). 1499–1505. 8 indexed citations

18.

Mamede, Marcelo, Paula Abreu-e-Lima, M. Raquel Oliva, et al.. (2007). FDG-PET/CT Tumor Segmentation-Derived Indices of Metabolic Activity to Assess Response to Neoadjuvant Therapy and Progression-Free Survival in Esophageal Cancer. American Journal of Clinical Oncology. 30(4). 377–388. 70 indexed citations

19.

Mamon, Harvey J., et al.. (1991). Interleukin-2-Triggered Raf-1 Expression, Phosphorylation, and Associated Kinase Activity Increase through G ₁ and S in CD3-Stimulated Primary Human T Cells. Molecular and Cellular Biology. 11(5). 2794–2803. 73 indexed citations

20.

Li, Ping, et al.. (1991). Raf-1: A kinase currently without a cause but not lacking in effects. Cell. 64(3). 479–482. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact